Ganciclovir: a review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections
D Faulds, RC Heel - Drugs, 1990 - Springer
Synopsis Ganciclovir is a nucleoside analogue with antiviral activity in vitro against
members of the herpes group and some other DNA viruses. It has demonstrated efficacy …
members of the herpes group and some other DNA viruses. It has demonstrated efficacy …
Ganciclovir: an update of its therapeutic use in cytomegalovirus infection
A Markham, D Faulds - Drugs, 1994 - Springer
Synopsis The antiviral nucleoside analogue ganciclovir has demonstrated in vitro activity
against human cytomegalovirus and effectively treats infection caused by this organism in …
against human cytomegalovirus and effectively treats infection caused by this organism in …
Human pharmacokinetics and tolerance of oral ganciclovir
MA Jacobson, P de Miranda… - Antimicrobial agents …, 1987 - Am Soc Microbiol
Ganciclovir is a nucleoside analog which inhibits the replication of herpesviruses in vitro and
which has been effective by intravenous administration for the treatment of severe …
which has been effective by intravenous administration for the treatment of severe …
Antiviral activity and mechanism of action of ganciclovir
T Matthews, R Boehme - Reviews of infectious diseases, 1988 - academic.oup.com
Abstract Ganciclovir (9-[(1, 3-dihydroxy-2-propoxy) methyl] guanine) is a potent inhibitor of
viruses of the herpes family, including cytomegalovirus (CMV), that are pathogenic for …
viruses of the herpes family, including cytomegalovirus (CMV), that are pathogenic for …
Ganciclovir for the treatment and suppression of serious infections caused by cytomegalovirus
OL Laskin, DM Cederberg, J Mills, LJ Eron… - The American journal of …, 1987 - Elsevier
Ganciclovir is a congener of acyclovir with in vitro activity against cytomegalovirus. Ninety-
seven patients with the acquired immune deficiency syndrome (AIDS) and a serious …
seven patients with the acquired immune deficiency syndrome (AIDS) and a serious …
Ganciclovir: an update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients
JK McGavin, KL Goa - Drugs, 2001 - Springer
Ganciclovir is a nucleoside guanosine analogue which incorporates ganciclovir
triphosphate (the active moiety) into DNA during elongation, thereby inhibiting viral …
triphosphate (the active moiety) into DNA during elongation, thereby inhibiting viral …
Ganciclovir treatment of life-or sight-threatening cytomegalovirus infection: experience in 314 immunocompromised patients
WC Buhles Jr, RJ Mastre, AJ Tinker… - Reviews of infectious …, 1988 - academic.oup.com
A total of 314 immunocompromised patients with serious cytomegalovirus (CMV) infection
treated with ganciclovir administered intravenously were studied. Rates of favorable clinical …
treated with ganciclovir administered intravenously were studied. Rates of favorable clinical …
Clinical pharmacokinetics of ganciclovir in patients with normal and impaired renal function
JP Sommadossi, R Bevan, T Ling, F Lee… - Reviews of Infectious …, 1988 - academic.oup.com
The pharmacokinetics of ganciclovir was evaluated in 21 patients with life-or sight-
threatening cytomegalovirus infections. Thirteen patients had normal renal function and …
threatening cytomegalovirus infections. Thirteen patients had normal renal function and …
Synergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in vitro
JF Manischewitz, GV Quinnan Jr… - Antimicrobial agents …, 1990 - Am Soc Microbiol
Ganciclovir and foscarnet possess substantial activity against cytomegalovirus. Both exhibit
dose-limiting toxicity, which reduces their clinical usefulness. We demonstrated synergistic …
dose-limiting toxicity, which reduces their clinical usefulness. We demonstrated synergistic …
Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts
A Erice, MC Jordan, BA Chace, C Fletcher… - Jama, 1987 - jamanetwork.com
Thirty-one immunocompromised patients with severe cytomegalovirus (CMV) disease were
treated with intravenous ganciclovir. Twenty-one patients had received transplants—15 …
treated with intravenous ganciclovir. Twenty-one patients had received transplants—15 …
相关搜索
- therapeutic efficacy cytomegalovirus infections
- pharmacokinetic properties cytomegalovirus infections
- therapeutic efficacy pharmacokinetic properties
- immunocompromised patients cytomegalovirus infection
- transplant recipients cytomegalovirus infection
- mechanism of action antiviral activity
- prevention of cytomegalovirus infection and disease
- ganciclovir and foscarnet cytomegalovirus replication
- ganciclovir treatment cytomegalovirus infection
- clinical pharmacokinetics ganciclovir in patients
- oral ganciclovir human pharmacokinetics
- ganciclovir and foscarnet synergistic effect
- renal function ganciclovir in patients
- transplant recipients cytomegalovirus disease
- ganciclovir treatment immunocompromised patients
- transplant recipients ganciclovir treatment